Starbucks is closing 100 stores and cutting 900 jobs in a major restructuring effort aimed at improving profitability. This strategic contraction could create a significant opportunity for competing coffee chains and quick-service restaurants to capture market share.
Published on October 5
Starbucks' strategic retreat creates immediate opportunities for competitors to capture displaced customers and expand their market presence in prime locations.
Companies that quickly capitalise on this competitive vacuum could see accelerated growth as they attract customers seeking new coffee and dining options.
These stocks were carefully selected by professional analysts for their strategic positioning to benefit from this specific industry shake-up and market opportunity.
When a market leader like Starbucks reduces its footprint through store closures, it creates a competitive vacuum that savvy competitors can exploit. This strategic shift from expansion to profitability signals a broader industry change, presenting tactical investment opportunities for companies positioned to capture displaced customers and market share in affected areas.
This group focuses on quick-service restaurants and coffee chains that could benefit from Starbucks' restructuring. These companies compete through convenience, value, and unique offerings. The investment opportunity is event-driven and tactical, centred on a specific industry disruption that could drive near-term growth for well-positioned competitors.
Each company in this curated selection was handpicked by professional analysts for their potential to benefit from the competitive opportunity created by Starbucks' store closures. These businesses have strong market positions, compelling alternative offerings, or strategic presence in areas that could capture displaced customers and gain market share.
Market cap breakdown for the 'Coffee Market Shake-Up' basket, showing heavy weighting toward the largest constituents.
SBUX: $98.23B
MCD: $214.78B
QSR: $22.45B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+6
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+44.75%
On average, analysts expect assets in this group to grow 44.75% over the next year.
12 of 16 assets in this group are rated Buy by professional analysts.
